Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127174692 | 12717469 | 2 | F | 201511 | 20160908 | 20160906 | 20160921 | EXP | GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-119488 | RANBAXY | 50.00 | YR | F | Y | 0.00000 | 20160921 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127174692 | 12717469 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 10 MILLIGRAM DAILY | 77032 | 10 | MG | ||||||||
| 127174692 | 12717469 | 2 | SS | Actavis UK Citalopram | CITALOPRAM HYDROBROMIDE | 1 | Oral | 20 MG, DAILY | UNKNOWN | 0 | 20 | MG | |||||||
| 127174692 | 12717469 | 3 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127174692 | 12717469 | 1 | Anxiety |
| 127174692 | 12717469 | 2 | Anxiety |
| 127174692 | 12717469 | 3 | Abdominal pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127174692 | 12717469 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127174692 | 12717469 | Abdominal pain upper | |
| 127174692 | 12717469 | Cerebral haemorrhage | |
| 127174692 | 12717469 | Cerebrovascular accident | |
| 127174692 | 12717469 | Head injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |